Conversely, the inhibition of AMPKα1 promoted the development of NAFLD in HFD mice through increasing adipocyte-mediated CD36-containing exosomes release. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.